Darwin Wealth Management LLC Takes Position in Humana Inc. (NYSE:HUM)

Darwin Wealth Management LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 285 shares of the insurance provider’s stock, valued at approximately $90,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bessemer Group Inc. grew its stake in shares of Humana by 143.4% during the first quarter. Bessemer Group Inc. now owns 6,436 shares of the insurance provider’s stock valued at $2,230,000 after buying an additional 3,792 shares during the last quarter. Lake Street Advisors Group LLC grew its position in Humana by 17.1% in the 1st quarter. Lake Street Advisors Group LLC now owns 1,124 shares of the insurance provider’s stock worth $391,000 after purchasing an additional 164 shares during the period. Pitcairn Co. grew its position in shares of Humana by 23.0% during the 1st quarter. Pitcairn Co. now owns 1,672 shares of the insurance provider’s stock valued at $580,000 after acquiring an additional 313 shares during the period. Advisors Asset Management Inc. lifted its stake in shares of Humana by 4.5% during the 1st quarter. Advisors Asset Management Inc. now owns 5,370 shares of the insurance provider’s stock valued at $1,862,000 after buying an additional 230 shares in the last quarter. Finally, Capital International Inc. CA lifted its stake in shares of Humana by 24.4% during the 1st quarter. Capital International Inc. CA now owns 12,809 shares of the insurance provider’s stock valued at $4,441,000 after buying an additional 2,512 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of HUM opened at $294.02 on Thursday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $527.18. The company has a market cap of $35.40 billion, a price-to-earnings ratio of 26.04, a price-to-earnings-growth ratio of 2.19 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a fifty day moving average of $277.86 and a 200-day moving average of $331.03.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.20%. Humana’s payout ratio is presently 31.36%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Oppenheimer lowered their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. KeyCorp initiated coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Royal Bank of Canada lowered their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research note on Tuesday, October 8th. Finally, TD Cowen boosted their target price on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.